The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-UK blue chips end higher as telecoms group BT surges on stake buy

Thu, 10th Jun 2021 08:53

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* AstraZeneca, pharma stocks lead gains

* Investors shrug off spike in U.S. inflation

* BT tops FTSE 100 after Altice takes 12% stake

* FTSE 100 up 0.1%, FTSE 250 down 0.7%
(Updates to close)

By Sagarika Jaisinghani and Sruthi Shankar

June 10 (Reuters) - Britain's blue-chip index closed
slightly higher on Thursday, aided by gains in telecoms group BT
and pharma majors, while doubts over the UK's reopening plans
later this month hurt the domestically focused mid-cap index.

Shares in BT Group jumped 6.6% to hit their highest
since January 2020 after telecoms billionaire Patrick Drahi's
Altice Group bought a 12.1% stake worth about 2.2
billion pounds ($3.1 billion), making it the largest
shareholder.

"Altice is an established name in the telecoms space and the
purchase of a 12% holding in BT is a significant move," said AJ
Bell investment director Russ Mould.

"It has been said for years that UK assets are cheap and
2021 is proving to be the year when investors finally put their
money where their mouth is."

The export-heavy FTSE 100 ended the day up 0.1%,
also boosted by drugmakers AstraZeneca and
GlaxoSmithKline.

Global stocks remained buoyant, with Wall Street's S&P 500
reaching a record high as investors took to the view that
a spike in May consumer prices was probably not enough to drive
an early policy tightening by the Federal Reserve.

The European Central Bank also pledged to keep monetary
policy loose despite lifting its growth and inflation
projections for the euro zone.

Stocks more exposed to the domestic economy took a hit, with
the UK's mid-cap index falling 0.7% in its third session
of losses amid doubts over a full reopening of the country on
June 21 as coronavirus cases pick-up again.

Meanwhile, Britain and the European Union failed to agree on
solutions to post-Brexit trade problems in Northern Ireland this
week, with the two sides exchanging threats, including
imposition of tariffs and quotas.

Among other stocks, facilities management provider Mitie
jumped 5.9% as it predicted its full-year profit would
beat current market estimates.

Online trading platform CMC Markets rose 1.7% as it
said annual profits had more than doubled.
(Reporting by Sagarika Jaisinghani in Bengaluru; editing by
Uttaresh.V and Mark Heinrich)

More News
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 17:10

Miners, personal goods stocks drag FTSE 100 to two-week low

Burberry slips on rating downgrade

*

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 12:10

LONDON MARKET MIDDAY: Stocks down before Fed minutes and US PMI data

(Alliance News) - Stock prices in London were down at midday on Wednesday, in cautious trade ahead of key US data and central bank minutes in the afternoon.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.